UA115257U - METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE - Google Patents

METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE

Info

Publication number
UA115257U
UA115257U UAU201610597U UAU201610597U UA115257U UA 115257 U UA115257 U UA 115257U UA U201610597 U UAU201610597 U UA U201610597U UA U201610597 U UAU201610597 U UA U201610597U UA 115257 U UA115257 U UA 115257U
Authority
UA
Ukraine
Prior art keywords
microcirculatory
determination
structural failure
blood
mitochondrial energy
Prior art date
Application number
UAU201610597U
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201610597U priority Critical patent/UA115257U/en
Publication of UA115257U publication Critical patent/UA115257U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)

Abstract

Спосіб визначення мікроциркуляторно-мітохондріальної енергоструктурної недостатності включає визначення серцевого індексу (СІ, л×хв×м). Додатково визначають концентрацію гемоглобіну крові (Нb, г×л), вміст кисню в артеріальній крові (СаО, мл×л), вміст кисню в венозній крові (CvO, мл×л) та артеріовенозну різницю вмісту кисню крові, що задовольняє енергетичні потреби організму (С, мл×л).The method for determining microcirculatory-mitochondrial energy-structural failure involves the determination of cardiac index (SI, l × min × m). Additionally determine the concentration of hemoglobin in blood (Hb, g × l), oxygen content in arterial blood (CaO, ml × l), oxygen content in venous blood (CvO, ml × l) and arteriovenous difference in blood oxygen content, which satisfies the energy needs of the body (C, ml × L).

UAU201610597U 2016-10-20 2016-10-20 METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE UA115257U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201610597U UA115257U (en) 2016-10-20 2016-10-20 METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201610597U UA115257U (en) 2016-10-20 2016-10-20 METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE

Publications (1)

Publication Number Publication Date
UA115257U true UA115257U (en) 2017-04-10

Family

ID=58531005

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201610597U UA115257U (en) 2016-10-20 2016-10-20 METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE

Country Status (1)

Country Link
UA (1) UA115257U (en)

Similar Documents

Publication Publication Date Title
EA201590062A1 (en) APPLICATION OF LEMON-ACID IRON IN THE TREATMENT OF PATIENTS WITH CHRONIC RENOVAL INSUFFICIENCY
MX2023000378A (en) Oxygen reduction disposable kits, devices and methods of use thereof.
BR112015012014A2 (en) dual specific binding proteins penetrating the blood brain barrier (bbb)
EA201492106A1 (en) METHOD AND DEVICE FOR THE CONTROL OF EXTRACTIONAL BLOOD TREATMENT OF THE PATIENT
TR201906285T4 (en) Removal of tumor cells from intraoperative autologous blood rescue.
MX2014011186A (en) Method of enhancing efficacy of blood transfusions.
EP3310256A4 (en) Transcutaneous measurement of hemoglobin changes to calculate estimated blood volume change during peritoneal dialysis
MX2016005734A (en) Ferric citrate for reducing cardiac failure in chronic kidney disease patients.
MX2020013301A (en) Methods and compositions for preventing or treating calciphylaxis.
MX2016012055A (en) Glycated protein assay.
MX2015001508A (en) The use of antithrombin in extracorporeal membrane oxygenation.
UA115257U (en) METHOD OF DETERMINATION OF MICROCIRCULATORY-MITOCHONDRIAL ENERGY STRUCTURAL FAILURE
UA115256U (en) METHOD OF DETERMINATION OF OXYGEN ENERGY STRUCTURAL FAILURE
EA201692161A1 (en) PROGEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
UA86387U (en) Method for evaluation of effectiveness of treatment of patients with arterial hypertension combined with metabolic syndrome
UA107451U (en) METHOD OF COMPLEX ASSESSMENT OF ERYTHROCYTIC RESISTANCE IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH STAGE WITH ANEMIA, TREATED BY NIRCINOSYASINOSIS
TR201902349A2 (en) BALLOON ASPIRATION CATHETER SYSTEM
CY1124001T1 (en) BLOOD PURIFYING LIQUID FREE FROM CALCIUM
BR112012009462A2 (en) antibodies, systems and methods for determining the relative hemolytic index
RU2010121221A (en) METHOD FOR DETERMINING VENOUS STagnation BY THE GREAT CIRCULATION OF BLOOD CIRCULATION IN PATIENTS WITH CHRONIC HEART FAILURE
RU2013112416A (en) METHOD FOR RESEARCH OF THE REACTION OF A HUMAN ORGANISM IN TRANSFUSION OF ERYTHROMASS
SG10201807066UA (en) Peptides and methods of use
Mal'chevskiĭ Character of changes in the rheological parameters of blood in patients with heart failure III-IV FC treated by the combination therapy with plasmapheresis
RU2014119325A (en) A method for predicting the risk of chronic atrial fibrillation in patients with cardiovascular disease
UA62757U (en) Method for prediction of adequacy of program hemodialysis in patients with chronic kidney disorder of v stage